P P A, LLC United States

We provide life cycle management solutions for innovator and branded pharmaceutical, medical device, biological products manufacturers. This entails winning difficult-to-obtain patents, designing Intellectual Property strategy and enforcing intellectual property to maintain market share.

I will shortly begin to interview companies able to register and launch a new US Rx product outside the US.  Partner companies must have (a) a women's health or rheumatology sales force; (b) experience registering hormone products; and (c) the ability to move quickly. 

Mr Mark POHL
Business Development and IP Counsel 

P2Link United States

INNOVATIVE AND EFFICIENT SOLUTIONS IN TELEMEDICINE First international research center for advanced telemedicine services developing efficient solutions for the management of chronic diseases.   CLINICAL EXPERTISE

Based on a fifteen years experience leveraging innovative R & D solutions geared towards chronic disease patients.

  CHRONIC DISEASES

Dedicated to selected chronic diseases leading to an efficient management of the healthcare costs, enhanced patient benefits and improved quality of life.

  NETWORK

A strong value-added connected health information system and a proven expertise in home healthcare through a series of programs closely connecting patients with health professionals.

  TEAM

An international multidisciplinary team with a proven record in the areas of healthcare, patient care, connected and social computer networks, design and ergonomics and health policy issues.

  WORLDWIDE

First transatlantic organization in Applied Telemedicine, offering cost efficient solutions to healthcare payers.

  SECURITY

An expertise and proven experience implemented in Europe and complying with stringent privacy and personal information laws for personal health information at the payer, provider and patient level.

Nabil Mouline
Chief Operating Officer 

P2Link United States

INNOVATIVE AND EFFICIENT SOLUTIONS IN TELEMEDICINE
First international research center for advanced telemedicine services developing efficient solutions for the management of chronic diseases
Paul Verdiel MD
CEO 

Pact & Partners United States

Mr John Levesque
International Consultant 

Pact & Partners United States

YOUR ONE-STOP-SHOP
FOR LOCAL & GLOBAL EXECUTIVE RECRUITMENTS

Pact & Partners is solely dedicated to Life Sciences. Within this industry, 
we cover every sector while keeping track of innovative markets. With proven expertise since 1987,
our track-record of appointments covers the full spectrum of the organizational chart.

Mr Olivier Safir
Senior Partner / CEO 

PAGER United States

Robert Boxer
Chief TeleHealth Innovation Officer 

Palladio Biosciences United States

Dr Lorenzo Pellegrini
CEO 

Parks Pharma Consulting United States

Mr Nigel Thompson
Partner 

Pershing Square Sohn Cancer Research Alliance United States

Our Mission

The Pershing Square Sohn Cancer Research Alliance is dedicated to playing a catalytic role in accelerating cures for cancer by enabling the pursuit of the most innovative and advanced cancer research and by facilitating collaborations between science and business.

The Alliance will launch a series of initiatives to further its Mission.

Our Story

Karen and Bill Ackman established The Pershing Square Foundation in December 2006. Bill is the CEO and Portfolio Manager of Pershing Square Capital Management, L.P. Based in New York, The Pershing Square Foundation has committed close to $350 million in grants and social investments to support exceptional leaders and innovative organizations that tackle important social issues and deliver scalable and sustainable impact across the globe.

The Foundation’s commitment to be a philanthropic catalyst inspired Bill Ackman to partner with The Sohn Conference Foundation to accelerate cures for cancer. The Sohn Conference Foundation was born from the loss of Ira Sohn, a Wall Street professional who succumbed to cancer at 29. In 1995, his colleagues, friends, and family joined forces to honor his memory. The Sohn Conference Foundation is dedicated to supporting innovative initiatives to cure and treat pediatric cancer. Identifying specific areas of need, the Foundation funds groundbreaking research, state-of-the-art technology, and programs to target cures and improve patient care.

The alliance of these two foundations will leverage their respective resources, their investigators, and their opportunities to exponentially impact the field of cancer research.

Olivia Tournay Flatto
Executive Director 

Pfizer United States

Novel target discovery. 
•Biotherapeutic (Immunotherapy & ADC) early discovery.
•Biotherapeutic (Immunotherapy & ADC) design and development.
•Intrapreneurship.
•Duties with Pfizer External R&D Innovation & Scouting for novel technologies in therapeutics, diagnostics & medical devices: 
(Screen & evaluate early/mid stage (inter)national biotech/pharma technologies that 
align with Pfizer’s R&D interest/vision & aid with triaging and funding of such technologies toward
corporate strategic partnerships). 
•NYC Bio-entrepreneurship mentor for early stage life science ventures through Pfizer Business 
Development and the New York Economic Development Council (ELabNYC, British Consulate, Columbia University).
•Adjunct Faculty member for National Science Foundation (NSF) I-Corps: 
The NYC Regional Innovation Node (NYCRIN): Bioentrepreneurship ventures.

Anton Xavier
Senior Scientist / Scout